PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9438384-9 1998 Butyrolactone I, an inhibitor of cdc2 kinase, inhibited increases in Cx43 phosphorylation during mitosis. butyrolactone I 0-15 cyclin dependent kinase 1 Homo sapiens 33-37 7592534-3 1995 Most of this phosphorylation and electrophoretic mobility shift, that occurred in the brain extract incubated with ATP, were inhibited by butyrolactone I, a specific inhibitor of cdc2 kinase and cdk5. butyrolactone I 138-153 cyclin dependent kinase 1 Homo sapiens 179-183 9042196-0 1996 Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines. butyrolactone I 21-36 cyclin dependent kinase 1 Homo sapiens 50-54 9042196-1 1996 Butyrolactone I, which is a naturally occurring specific inhibitor of the cdc2 kinase family, showed antitumor effects on several non-small- and small-cell-lung cancer cell lines with IC50 values the order of 50 micrograms/ml on the former. butyrolactone I 0-15 cyclin dependent kinase 1 Homo sapiens 74-78 9371520-6 1997 Consistent with this, Thr14/Tyr15 phosphorylation was induced when Cdc2 kinase activity was inhibited with butyrolactone-I. butyrolactone I 107-122 cyclin dependent kinase 1 Homo sapiens 67-71 8910474-6 1996 Fas-induced apoptosis was completely inhibited by butyrolactone I, a specific inhibitor of Cdc2 kinase. butyrolactone I 50-65 cyclin dependent kinase 1 Homo sapiens 91-95 7574801-4 1995 Butyrolactone I inhibits both cdc2 and CDK2 kinase in the cell-free system. butyrolactone I 0-15 cyclin dependent kinase 1 Homo sapiens 30-34 8058318-1 1994 Butyrolactone I is a selective inhibitor of the cyclin-dependent kinase (cdk) family. butyrolactone I 0-15 cyclin dependent kinase 1 Homo sapiens 73-76